These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1367502)

  • 1. Purification and production of therapeutic grade proteins.
    Garg VK; Costello MA; Czuba BA
    Bioprocess Technol; 1991; 12():29-54. PubMed ID: 1367502
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality control of rDNA-derived human tissue-type plasminogen activator.
    Jones AJ; Garnick RL
    Bioprocess Technol; 1990; 10():543-66. PubMed ID: 1367501
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recombinant DNA technology in thrombolytic therapy: tissue-type plasminogen activator].
    Mazza P
    Boll Chim Farm; 1991 Mar; 130(3):105-7. PubMed ID: 1909876
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory and clinical experience with recombinant plasminogen activator.
    Builder SE; Grossbard E
    Prog Clin Biol Res; 1986; 211():303-13. PubMed ID: 3083430
    [No Abstract]   [Full Text] [Related]  

  • 5. rtPA is a well-characterized protein.
    O'Connor JV
    Dev Biol Stand; 1998; 96():113-21. PubMed ID: 9890524
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue-type plasminogen activator: a historical perspective and personal account.
    Collen D; Lijnen HR
    J Thromb Haemost; 2004 Apr; 2(4):541-6. PubMed ID: 15102005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms.
    Johnsen LB; Ravn P; Berglund L; Petersen TE; Rasmussen LK; Heegaard CW; Rasmussen JT; Benfeldt C; Fedosov SN
    Biochemistry; 1998 Sep; 37(36):12631-9. PubMed ID: 9730836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-type plasminogen activator.
    Little C
    Heart Lung; 1987 Jul; 16(4):463. PubMed ID: 3110108
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drugs produced by genetic techniques].
    Bicker U
    Verh Dtsch Ges Inn Med; 1990; 96():451-65. PubMed ID: 2128725
    [No Abstract]   [Full Text] [Related]  

  • 10. Boehringer Mannheim's new clot buster.
    Nat Biotechnol; 1997 Feb; 15(2):114. PubMed ID: 9035121
    [No Abstract]   [Full Text] [Related]  

  • 11. The tissue-type plasminogen activator story.
    Collen D; Lijnen HR
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary thrombolysis with tissue-type plasminogen activator: an overview.
    Van de Werf F; Collen D
    Eur Heart J; 1985 Nov; 6(11):902-4. PubMed ID: 3935445
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization studies of human tissue-type plasminogen activator produced by recombinant DNA technology.
    Vehar GA; Spellman MW; Keyt BA; Ferguson CK; Keck RG; Chloupek RC; Harris R; Bennett WF; Builder SE; Hancock WS
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 1():551-62. PubMed ID: 2953546
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale processing & high-throughput perfusion chromatography.
    Fulton SP; Shahidi AJ; Gordon NF; Afeyan NB
    Biotechnology (N Y); 1992 Jun; 10(6):635-9. PubMed ID: 1368883
    [No Abstract]   [Full Text] [Related]  

  • 16. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 17. Purified protein products of rDNA technology expressed in animal cell culture.
    Lubiniecki AS; Lupker JH
    Biologicals; 1994 Jun; 22(2):161-9. PubMed ID: 7522477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Care of the patient receiving recombinant tissue plasminogen activator.
    White-Williams C
    J Cardiovasc Nurs; 1989 Nov; 4(1):62-7. PubMed ID: 2513380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator for stroke in Israel: the time has finally come.
    Leker RR
    Isr Med Assoc J; 2004 Feb; 6(2):95-6. PubMed ID: 14986466
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue plasminogen activator after retinal artery occlusion.
    Marmor MF
    Ophthalmology; 1999 Dec; 106(12):2231-2. PubMed ID: 10599645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.